CMND - Clearmind Medicine Inc.

Stock Grade Analysis

General Rating

C+
Overall Score: 2/5
Multi-dimensional Scores
DCF: 3/5 ROE: 1/5 ROA: 1/5 D/E: 4/5 P/E: 1/5
Financial Ratios Trend

Grades Consensus

No grades consensus data available.

Grade News & Updates

Date Grading Company New Grade Previous Grade Action Price When Posted News Title Publisher
2026-04-16 Piper Sandler Overweight N/A Initialise $0.6143 Psychedelic: Clearmind's CMND-100 meets primary endpoint in… TheFly
2026-04-16 Jefferies Buy N/A Initialise $0.6143 Psychedelic: Clearmind's CMND-100 meets primary endpoint in… TheFly
2026-04-16 Cowen & Co. Buy N/A Initialise $0.6143 Psychedelic: Clearmind's CMND-100 meets primary endpoint in… TheFly